Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MB-CART19.1 CD19 CAR T in adult relapsed/refractory B-ALL
NCT07890025Phase 2Not yet recruiting
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Dec 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 2 trial of zorpocabtagene autoleucel in B cell acute lymphoblastic leukemia (B-ALL), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
zorpocabtagene autoleucel
03
Conditions
B cell acute lymphoblastic leukemia (B-ALL)
Beyond the preview
Go deeper on NCT07890025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07890025.